Another Hydroxycholoroquine Study
-
Hopefully the numbers are reliable in this one:
No value in prophylaxis:
Results published online Wednesday by the New England Journal of Medicine showed little difference in the onset of COVID-19 in 414 people who took hydroxychloroquine and a comparison group of 407 that took only folic acid vitamins. All participants had at least moderate risk for COVID-19 after being exposed to others in their homes or workplaces who had the illness.
There was a small difference, as 11.8% of people taking the drug developed COVID-19, compared with 14.3% of those taking vitamins, the study showed. However, that difference was considered statistically insignificant.
What about treatment?
A separate U trial is examining whether it benefits patients after early onset of symptoms, but results haven’t been published.
What about zinc?
While not a primary goal, the study also found no increased protection for participants who also took zinc or vitamin C. A separate study suggested that zinc could boost the effectiveness of chloroquine, but even if that’s true, the U authors noted that most Americans consume enough zinc already so supplements shouldn’t be needed.
-
For a while now we are getting the sense that the early studies were bogus. That’s disappointing but a reality.
Remdesivir seems to be holding up a little better but appears to not to be a panacea.
I hope the vaccines, the antibody tests and the antibodies hold up better under scrutiny. But our first two examples provide caution.
-
-
@Loki said in Another Hydroxycholoroquine Study:
“At a press conference on Wednesday, the WHO announced it would resume its global trial of hydroxychloroquine, after its data safety monitoring committee found there was no increased risk of death for Covid patients taking it.“
Isn't it funny how the "science" of the WHO keeps changing? I'm so old that I remember them telling us the rest of human-human transmission was small. Seems like they'll believe anyone who tells them what they want to hear, until reality hits them in the face.
-
@George-K said in Another Hydroxycholoroquine Study:
@Loki said in Another Hydroxycholoroquine Study:
“At a press conference on Wednesday, the WHO announced it would resume its global trial of hydroxychloroquine, after its data safety monitoring committee found there was no increased risk of death for Covid patients taking it.“
Isn't it funny how the "science" of the WHO keeps changing? I'm so old that I remember them telling us the rest of human-human transmission was small. Seems like they'll believe anyone who tells them what they want to hear, until reality hits them in the face.
Yeah but what’s great are the people who love the WHO are not going to promote this fact. Even you didn’t see it yesterday.
-
Interesting story that indicated that WHO was frustrated with China in private, but of course did not talk about those frustrated in public. They probably should have.
-
Famotodine is still showing well. Another very small study with outpatients...
